Cargando…
Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smea...
Autores principales: | Otieno, Steve B, Ogbeide, Osarenren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188828/ https://www.ncbi.nlm.nih.gov/pubmed/35698717 http://dx.doi.org/10.7759/cureus.24976 |
Ejemplares similares
-
Managing Massive Splenic Hematoma: Exploratory Laparotomy or Active Surveillance?
por: Otieno, Steve B, et al.
Publicado: (2021) -
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022) -
Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients
por: Khorshid, Ola, et al.
Publicado: (2015) -
Outcome of hairy cell leukemia patients treated with cladribine – a 10-year single-center experience in Pakistan
por: Zahid, Mohammad Faizan, et al.
Publicado: (2019) -
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
por: Chihara, Dai, et al.
Publicado: (2021)